US 12398140
Substituted pyrrolo [2,3-d]pyrimidines for treating familial dysautonomia
granted A61PA61P25/00
Quick answer
US patent 12398140 (Substituted pyrrolo [2,3-d]pyrimidines for treating familial dysautonomia) held by PTC THERAPEUTICS, INC. expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P25/00